Navigation Links
Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
Date:1/24/2013

WAYNE, Pa., Jan. 24, 2013 /PRNewswire/ -- Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/mapp) is investigating potential claims against the board of directors of MAP Pharmaceuticals, Inc. ("MAP" or the "Company") (NASDAQ: MAPP) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Allergan, Inc. in a transaction valued at approximately $958 million.

(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO )

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to the approval of the transaction by the Company's board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of MAP.  For more information regarding our investigation, please contact Ryan & Maniskas, LLP ( Richard A. Maniskas, Esquire ) toll-free at (877) 316-3218 or by email at rmaniskas@rmclasslaw.com or visit: www.rmclasslaw.com/cases/mapp.Under the terms of the proposal, public shareholders of MAP will receive $25.00 per share in cash for each share of MAP they own.

If you own shares of MAP and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/mapp.  You may also email Mr. Manis
'/>"/>

SOURCE Ryan & Maniskas, LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...  Frequentz Inc., a global leader and champion of ... help the pharmaceutical industry understand the current and future ... (DSCSA). The white paper, "From Lot-based to Serialization-based Traceability", ... Standard(s) and Implementation Plan rollout, as well as ... that need to occur between now and the 2017 ...
(Date:3/31/2015)... 2015 Medela has announced the addition ... ® Motion™-Endure personal pumps to its Negative Pressure ... These new devices, along with the Invia ® ... provide innovative, high-quality NPWT solutions, designed to provide ... "We are happy to be able ...
(Date:3/31/2015)... PGI has announced an expansion of its ... at its San Luis Potosi, ... expansion is centered on solving the challenge of complicated ... personal care product manufacturers. The planned ... and packaging, will allow customers to take advantage of ...
Breaking Medicine Technology:Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2PGI Expands Manufacturing Capabilities At Mexico Plant 2
... Sept. 29, 2011 The U.S. Food and Drug ... the International Internet Week of Action (IIWA), a cooperative ... and illegal medical products. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... between Sept. 20 and Sept. 27 is called OPERATION ...
... Sept. 29, 2011 CIVCO ... installed at the Instituto Radioterapia del Este in Puerto ... the Protura system elevates the level of radiation therapy ... need for many patients to travel for treatment. ...
Cached Medicine Technology:FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 2FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 3FDA Participates in Global Efforts to Protect Consumers and Patients from Unsafe Drugs on the Internet 4CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 2CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 3
(Date:3/31/2015)... CT (PRWEB) March 31, 2015 Calling all ... against Lyme and other tick-borne diseases! The first annual “Lyme ... Cove Island Park in Stamford, CT. The event, hosted by ... (TBDA), will raise funds to support research and education ... event, open to all ages and abilities, will feature 5K ...
(Date:3/31/2015)... March 31, 2015 Medical DNA Labs, ... met all criteria for Laboratory Accreditation by COLA, a ... to laboratories that apply rigid standards of quality in ... proficiency testing, and pass a rigorous on-site laboratory survey. ... as a result of a long-term commitment to provide ...
(Date:3/31/2015)... March 31, 2015 Students, teachers, and ... for education in a drastically different way as current ... learning and training content is being delivered and received. ... by technology in an unprecedented way with education becoming ... Cumavoo, co-founder and CEO, My Mobile University , ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Clinovo, ... BayBio’s Membership Program , the premiere voice ... region’s 1300+ life science companies. , BayBio ... the world’s most innovative and productive life science ... solve some of humanity’s most pressing challenges. ...
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... the Institute for Advanced Reconstruction. He was recently quoted ... condition is caused by lymphatic issues, causing fluid retention and ... performing the procedure to relieve and / or improve lymphedema ... is to improve or alleviate the symptoms of lymphedema. ...
Breaking Medicine News(10 mins):Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4
... form multiple sclerosis had showed marked improvement for ... results of the investigation were reported in the ... ,Although two-thirds of depressed patients prefer psychotherapy to ... a first appointment and nearly half will drop ...
... reduces the spread of gastrointestinal infections in the home. ... the families, which used the hand sanitizer in gel ... of illness related to the gastrointestinal tract. ... study. Half the families were randomly assigned to receive ...
... very old days and it continues to enjoy the privilege ... able to substitute mankind with another alternative. // Very little ... exercise in young competitors. The benefits versus the hazards of ... research has reported that adolescents and young adults involved in ...
... of fibres further by stating that cereal fibre and ... the arteries in postmenopausal women.// ,Previous studies ... risk of heart disease and death. Investigating the effect ... and refined grain products on the progression of existing ...
... Ramadoss Monday said that the government would include ... as it has been emerging as a "problem ... of an Indian Council of Medical Research (ICMR)-World ... diagnosis of leptospirosis at the regional ICMR centre ...
... National University of Singapore studied the effect of plutonium ... cancer// in Plutonium plant workers. The study ... and identification of chromosome aberrations. The study is also ... and disease condition which would be helpful in establishing ...
Cached Medicine News:Health News:MS Patients Improve With Telephone Therapy 2Health News:Alcohol based sanitizer found to reduce illness in families 2Health News:Competitive Sports: Is the heart Sportive Enough? 2
... Delta Specialty / Drug Clinical System ... can consolidate Drugs of Abuse, TDM's ... thyroid, HbA1c and lipids in one ... a level of automation and flexibility ...
The Rheumatoid Factor (RF) assay is used for the quantitative analysis of rheumatoid factor in human serum....
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w...
Medicine Products: